Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06415526
Status:
COMPLETED
Last Update Posted:
2024-05-16
First Post:
2024-05-10
Brief Title:
OPERA - Incorporating Robotic Surgery in Both Mastectomy and DIEP Flap Reconstruction
Sponsor:
Chang Gung Memorial Hospital
Organization:
Chang Gung Memorial Hospital
Study Overview
Official Title:
Oncoplastic Entirely Robot-Assisted Approach OPERA - Incorporating Robotic Surgery in Both Mastectomy and DIEP Flap Reconstruction
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Current breast cancer surgery is achieving minimally invasive approach to reduce incision while providing better surgical vision and freedom in mastectomy Breast reconstruction with free deep inferior epigastric artery perforator DIEP flap was considered the gold standard however the donor site morbidity remains an endless concern Here we applied robotic-assisted surgery in both mastectomy and free DIEP flap harvest so-called Oncoplastic Entirely Robot-Assisted Approach OPERA
A retrospective chart review identified 14 patients with unilateral breast cancer received robotic-assisted mastectomy and robotic assisted free DIEP flap harvest for breast reconstruction The patient demographics and mastectomy and flap characteristics were reviewed
A retrospective chart review identified 14 patients with unilateral breast cancer received robotic-assisted mastectomy and robotic assisted free DIEP flap harvest for breast reconstruction The patient demographics and mastectomy and flap characteristics were reviewed
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None